Talk:Rifaximin
| This is the talk page for discussing improvements to the Rifaximin article. This is not a forum for general discussion of the article's subject. |
Article policies
|
| Find medical sources: Source guidelines · PubMed · Cochrane · DOAJ · Gale · OpenMD · ScienceDirect · Springer · Trip · Wiley · TWL |
 | This article is rated C-class on Wikipedia's content assessment scale. It is of interest to the following WikiProjects: | ||||||||||||||||||||
| |||||||||||||||||||||
 | Ideal sources for Wikipedia's health content are defined in the guideline Wikipedia:Identifying reliable sources (medicine) and are typically review articles. Here are links to possibly useful sources of information about Rifaximin.
|
i've the full clinical insert for this and have taken it myself -- Lieutenant Colonel Frank Slade 09:51, 2 July 2006 (UTC)
one of the most complex molecular structures i've ever seen in my life, too =) -- Lieutenant Colonel Frank Slade 09:55, 2 July 2006 (UTC)
mostly prescribed with people w/ ibs strictly for abdomninal pain -- although there have been trials to help the diarrhea, they've been mostly inconclusive. there is currently a crohn's colitis test going on with higher doses which looks much more promising (~1200mg/day) -- Lieutenant Colonel Frank Slade 11:43, 2 July 2006 (UTC)
Dead link edit
The link to the label information is broken. The correct link is this. Could someone with edit rights fix it? 81.99.218.67 (talk) 10:44, 19 March 2011 (UTC)
Approval in Canada edit
According to this link, this drug (under the trade name "Zaxine") has been approved for use in Canada as of October, 2013, and has been assigned a DIN as well:
http://www.hc-sc.gc.ca/dhp-mps/prodpharma/sbd-smd/drug-med/sbd_smd_2013_zaxine_161256-eng.php
Should the article be updated to reflect this? — Preceding unsigned comment added by EishethIntegra (talk • contribs) 05:09, 18 March 2014 (UTC)
Generic absorption differences edit
Article in question is not the direct source. Direct source indicates conflict of interest between researchers and Alfa Wassermann, the company that holds the patent. https://doi.org/10.1016/j.phrs.2014.05.001 — Preceding unsigned comment added by WereJesus (talk • contribs) 01:26, 4 April 2022 (UTC)
It is very expensive edit
My doctor presribed me this for irritable bowel. Because he is a GP and not a specialist, I have to pay full price, which is like AUD $500 for a 3 week course. 2001:8003:E490:7D01:89E1:A5F5:4162:44A2 (talk) 02:23, 23 June 2023 (UTC)